EmeisWBO:ORP2 +1.97%46 Days Payable is 135.95 as of Dec. 2025, which is 1% above its 10-year median of 135.06. GuruFocus rates WBO:ORP2 with a GF Score™ of 46/100 and a GF Value™ of €9.25 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Emeis ranks better than 77.56% on this metric.
Emeis's average Accounts Payable for the
six
months ended in Dec. 2025 was €434 Mil. Emeis's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €583 Mil.
Hence, Emeis's Days Payable for the
six
months ended in Dec. 2025 was 135.95.
The historical rank and industry rank for Emeis's Days Payable or its related term are showing as below:
WBO:ORP2'
s Days Payable Range Over the Past 10 Years
Min: 97.29 Med: 135.06 Max: 160.91
Current: 136.67
During the past 13 years, Emeis's highest Days Payable was 160.91. The lowest was 97.29. And the median was 135.06.
WBO:ORP2's Days Payable is ranked better than 77.56% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs WBO:ORP2: 136.67
Emeis's Days Payable
increased
from Dec. 2024 (115.97) to Dec. 2025 (135.95).
It may suggest that Emeisdelayed paying its suppliers.
Emeis Days Payable Related Terms
Emeis Days Payable Historical Data
* Premium members only.
The historical data trend for Emeis's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ORP2 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Emeis's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emeis Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Emeis's Days Payable distribution charts can be found below:
* The bar in red indicates where Emeis's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Emeis's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emeis (WBO:ORP2) has a Days Payable of 135.95 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Emeis and its competitors. This is near median its historical median of 135.06. Over the past decade, Emeis' Days Payable has ranged from 97.29 to 160.91. According to the industry distribution chart, Emeis ranks #136 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 22.4%.
Is Emeis' Days Payable too high?
Emeis' current Days Payable of 135.95 is near median its 10-year median of 135.06. Over the past 10 years, this metric has ranged from a low of 97.29 to a high of 160.91. The Healthcare Providers & Services industry median Days Payable is 58.21. Emeis' value of 135.95 is 133.6% above this industry median. Based on the distribution chart, Emeis ranks #136 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Emeis has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emeis' Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Emeis ranks #136 out of 606 companies for Days Payable. This places Emeis in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.21. Emeis' value of 135.95 is 133.6% above this benchmark. Historically, Emeis' own Days Payable has ranged from 97.29 to 160.91 over the past decade. While the company's 10-year median is 135.06 vs. the industry median of 58.21, Emeis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Emeis's current Days Payable of 135.95 is 133.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Emeis and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emeis's current Days Payable is 135.95, which is near median its own 10-year median of 135.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emeis stock overvalued right now?
Based on GuruFocus' analysis, Emeis (WBO:ORP2) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.25, compared to a current price of €14.49 — trading 56.6% above its estimated fair value. The current Days Payable is 135.95, which is near median its 10-year median of 135.06 and 133.6% above the Healthcare Providers & Services industry median of 58.21. Emeis' overall GF Score™ is 46/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Emeis (WBO:ORP2), the current Days Payable is 135.95 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Emeis (WBO:ORP2) Overvalued in 2026?
Based on GuruFocus' analysis, Emeis stock appears to be overvalued.
The current stock price of €14.49 is trading 56.6% above its estimated GF Value™ of €9.25.
GuruFocus considers Emeis to be Significantly Overvalued.
Key valuation signals for WBO:ORP2:
Days Payable: 135.95 (near median its 10-year median of 135.06)
GF Value™: €9.25 vs. price of €14.49 (56.6% above fair value)
Industry Position: 133.6% above the Healthcare Providers & Services median (#136 of 606)
No single metric tells the full story. See the WBO:ORP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
46GF Score
Get the complete analysis for WBO:ORP2
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ORP2 has been successfully added to your 
